INCOME TAXES	3 Months Ended
Mar. 30, 2019
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company’s effective tax rates for the three months ended March 30, 2019 and March 31, 2018 were 16.0% and 15.5%, respectively. The slight increase in the 2019 period compared to the 2018 period was primarily attributable to tax benefits from favorable tax authority rulings in the 2018 period, partially offset by increased tax benefits from stock-based compensation deductions in the 2019 period. For the three months ended March 30, 2019, the Company’s unrecognized tax benefits increased by $0.7 million to $19.5 million, primarily due to an additional quarter of Canadian Scientific Research and Experimental Development Credit reserves as well as unfavorable foreign exchange. For the three months ended March 30, 2019, the unrecognized income tax benefits that would impact the effective tax rate increased by $0.5 million to $18.1 million, for the same reasons listed above. The accrued interest on unrecognized tax benefits was $2.9 million at March 30, 2019. The Company estimates that it is reasonably possible that the unrecognized tax benefits will decrease by up to $8.2 million over the next twelve-month period, primarily due to the outcome of pending tax audits. The Company conducts business in several tax jurisdictions. As a result, it is subject to tax audits in jurisdictions including the U.S., U.K., China, France, Germany, Canada, Japan and India. With few exceptions, the Company is no longer subject to U.S. and international income tax examinations for years before 2015. The Company and certain of its subsidiaries have ongoing tax controversies with various tax authorities in the U.S., Canada, Japan, India and France. The Company does not anticipate resolution of these audits will have a material impact on its financial statements.

INCOME TAXES

The Company’s effective tax rates for the three months ended March 30, 2019 and March 31, 2018 were 16.0% and 15.5%, respectively. The slight increase in the 2019 period compared to the 2018 period was primarily attributable to tax benefits from favorable tax authority rulings in the 2018 period, partially offset by increased tax benefits from stock-based compensation deductions in the 2019 period.

For the three months ended March 30, 2019, the Company’s unrecognized tax benefits increased by $0.7 million to $19.5 million, primarily due to an additional quarter of Canadian Scientific Research and Experimental Development Credit reserves as well as unfavorable foreign exchange. For the three months ended March 30, 2019, the unrecognized income tax benefits that would impact the effective tax rate increased by $0.5 million to $18.1 million, for the same reasons listed above. The accrued interest on unrecognized tax benefits was $2.9 million at March 30, 2019. The Company estimates that it is reasonably possible that the unrecognized tax benefits will decrease by up to $8.2 million over the next twelve-month period, primarily due to the outcome of pending tax audits.

The Company conducts business in several tax jurisdictions. As a result, it is subject to tax audits in jurisdictions including the U.S., U.K., China, France, Germany, Canada, Japan and India. With few exceptions, the Company is no longer subject to U.S. and international income tax examinations for years before 2015.

The Company and certain of its subsidiaries have ongoing tax controversies with various tax authorities in the U.S., Canada, Japan, India and France. The Company does not anticipate resolution of these audits will have a material impact on its financial statements.